Hannah R. Cock

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

Jaideep Kapur, Jordan Elm, James M. Chamberlain et al. · New England Journal of Medicine · 2019 · 521 citations · Full text

Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial

Laura H. Goldstein, Emily Robinson, John D. C. Mellers et al. · The Lancet Psychiatry · 2020 · 268 citations · Full text

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

James M. Chamberlain, Jaideep Kapur, Shlomo Shinnar et al. · The Lancet · 2020 · 225 citations · Full text

Age Group, Neuropharmacology, Status Epilepticus +4

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 202 citations · Full text

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 183 citations · Full text